MACROGENICS, INC. Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount
MACROGENICS, INC. (MGNX) reported Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount of $388.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-20.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherReconcilingItems · last filed 2025-03-20
- MACROGENICS, INC. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2024 was $388.00K, a 70.18% decline from fiscal 2023.
- MACROGENICS, INC. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2023 was $1.30M, a 4.48% decline from fiscal 2022.
- MACROGENICS, INC. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2022 was $1.36M, a 13.59% increase from fiscal 2021.
- MACROGENICS, INC. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2021 was $1.20M, a 3.72% increase from fiscal 2020.
| Period end | Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount 12 month | Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount 12 month as first filed |
|---|---|---|
| 2024-12-31 | $388.00K 10-K · filed 2025-03-20 | |
| 2023-12-31 | $1.30M 10-K · filed 2025-03-20 | |
| 2022-12-31 | $1.36M 10-K · filed 2025-03-20 | |
| 2021-12-31 | $1.20M 10-K · filed 2024-03-07 | |
| 2020-12-31 | $1.16M 10-K · filed 2023-03-15 | |
| 2019-12-31 | $1.21M 10-K · filed 2022-02-24 | |
| 2018-12-31 | $148.00K 10-K · filed 2021-02-25 | |
| 2017-12-31 | $276.00K 10-K · filed 2020-02-25 | |
| 2016-12-31 | $145.00K 10-K · filed 2019-02-26 | |
| 2015-12-31 | -$25.00K 10-K · filed 2018-02-27 | |
| 2014-12-31 | -$382.00K 10-K · filed 2017-02-28 | |
| 2013-12-31 | $3.00K 10-K · filed 2016-02-29 | $2.93K 10-K · filed 2014-03-20 |
| 2012-12-31 | $8.00K 10-K · filed 2015-03-03 | $7.63K 10-K · filed 2014-03-20 |
| 2011-12-31 | $4.70K 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |